Venigalla Rao

Last updated

Venigalla B. Rao
Born
Alma mater Indian Institute of Science
Andhra University
Scientific career
Institutions University of Maryland School of Medicine, Baltimore
The Catholic University of America
Website t4 Lab

Venigalla Basaveswara Rao is an Indian-American biochemist who is a professor of biology at the Catholic University of America. He serves as Director of the Bacteriophage Medical Research Center. In 2021, he was elected a Fellow of the American Society for Microbiology and the National Academy of Inventors.

Contents

Early life and education

Rao was born in Donepudi, a village in Andhra Pradesh. [1] His family owned a small farm. [1] Rao enrolled at a college ten miles from his home, and rode a bicycle there and back every day. At college he became interested in chemistry. [1] He was an undergraduate at Andhra University, where he specialized in biochemistry. [1] He completed his doctoral research at the Indian Institute of Science, where he focused on enzyme engineering. [1] As a postdoctoral fellow, he was introduced to bacteriophages at the University of Maryland, Baltimore County. Over the course of his fellowship, Rao developed strategies to control the assembly of bacteriophage t4 in a test tube. [1]

Research and career

Rao works on bacteriophages to understand the mechanisms of DNA packaging in double-stranded icosahedral viruses. [2] His early work explored the molecular structures that underpinned the DNA packaging machine, the motor and the capsid. [1] He studied the fastest and most effective DNA packaging machine ever known, [3] the large icosahedral virus bacteriophage T4. [4] The motor (17 nm wide and 9 nm high) would be more powerful than that of a car engine if it were scaled. [1]

Rao joined the Catholic University of America in 1989, [5] where he has served as an associate professor, full professor, chair and director. He has investigated the application of bacteriophage T4 in vaccines against HIV/AIDS, [6] the flu, [1] the plague and anthrax. [7] He argued that such vaccines would be more cost-effective, easier to administer and provide more long-term protection. [1] Rao developed a nasal vaccine to tackle COVID-19. [8] The needle-free vaccine is a noninfectious bacteriophage t4-based multi-component vaccine that contains spike trimers. [9] The vaccine is created by tailoring a harmless Bacteriophage t4 ( Escherichia virus ) virus, such that it delivers an antidote to COVID-19. [10] These nasal vaccines may induce immunity in the mucus lining, which could prevent viral transmission. [11] [12]

Awards and honors

Selected publications

Related Research Articles

<span class="mw-page-title-main">Bacteriophage</span> Virus that infects and replicates within bacteria

A bacteriophage, also known informally as a phage, is a duplodnaviria virus that infects and replicates within bacteria and archaea. The term was derived from "bacteria" and the Greek φαγεῖν, meaning "to devour". Bacteriophages are composed of proteins that encapsulate a DNA or RNA genome, and may have structures that are either simple or elaborate. Their genomes may encode as few as four genes and as many as hundreds of genes. Phages replicate within the bacterium following the injection of their genome into its cytoplasm.

<span class="mw-page-title-main">Capsid</span> Protein shell of a virus

A capsid is the protein shell of a virus, enclosing its genetic material. It consists of several oligomeric (repeating) structural subunits made of protein called protomers. The observable 3-dimensional morphological subunits, which may or may not correspond to individual proteins, are called capsomeres. The proteins making up the capsid are called capsid proteins or viral coat proteins (VCP). The capsid and inner genome is called the nucleocapsid.

<span class="mw-page-title-main">DNA vaccine</span> Vaccine containing DNA

A DNA vaccine is a type of vaccine that transfects a specific antigen-coding DNA sequence into the cells of an organism as a mechanism to induce an immune response.

<i>Adenoviridae</i> Family of viruses

Adenoviruses are medium-sized, nonenveloped viruses with an icosahedral nucleocapsid containing a double-stranded DNA genome. Their name derives from their initial isolation from human adenoids in 1953.

<i>Escherichia virus T4</i> Species of bacteriophase

Escherichia virus T4 is a species of bacteriophages that infect Escherichia coli bacteria. It is a double-stranded DNA virus in the subfamily Tevenvirinae from the family Myoviridae. T4 is capable of undergoing only a lytic lifecycle and not the lysogenic lifecycle. The species was formerly named T-even bacteriophage, a name which also encompasses, among other strains, Enterobacteria phage T2, Enterobacteria phage T4 and Enterobacteria phage T6.

<span class="mw-page-title-main">Filamentous bacteriophage</span> Family of viruses

Filamentous bacteriophage is a family of viruses (Inoviridae) that infect bacteria. The phages are named for their filamentous shape, a worm-like chain, about 6 nm in diameter and about 1000-2000 nm long. The coat of the virion comprises five types of viral protein, which are located during phage assembly in the inner membrane of the host bacteria, and are added to the nascent virion as it extrudes through the membrane. This family's simplicity makes it an appealing model system to research fundamental molecular biology concepts, and it has also shown promise as a tool in nanotechnology and immunology.

<span class="mw-page-title-main">Caudovirales</span> Class of viruses

Caudoviricetes is an class of viruses known as the tailed bacteriophages. Under the Baltimore classification scheme, the Caudoviricetes are group I viruses as they have double stranded DNA (dsDNA) genomes, which can be anywhere from 18,000 base pairs to 500,000 base pairs in length. The virus particles have a distinct shape; each virion has an icosahedral head that contains the viral genome, and is attached to a flexible tail by a connector protein. The order encompasses a wide range of viruses, many containing genes of similar nucleotide sequence and function. However, some tailed bacteriophage genomes can vary quite significantly in nucleotide sequence, even among the same genus. Due to their characteristic structure and possession of potentially homologous genes, it is believed these bacteriophages possess a common origin.

Epsilon 15 is a virus, specifically a bacteriophage, known to infect species of Salmonella bacteria including Salmonella anatum.The virus is a short, tailed phage with a double-stranded DNA genome of 39,671 base pairs and 49 open reading frames.

<span class="mw-page-title-main">A-DNA</span>

A-DNA is one of the possible double helical structures which DNA can adopt. A-DNA is thought to be one of three biologically active double helical structures along with B-DNA and Z-DNA. It is a right-handed double helix fairly similar to the more common B-DNA form, but with a shorter, more compact helical structure whose base pairs are not perpendicular to the helix-axis as in B-DNA. It was discovered by Rosalind Franklin, who also named the A and B forms. She showed that DNA is driven into the A form when under dehydrating conditions. Such conditions are commonly used to form crystals, and many DNA crystal structures are in the A form. The same helical conformation occurs in double-stranded RNAs, and in DNA-RNA hybrid double helices.

<span class="mw-page-title-main">Bacillus virus phi29</span> Species of virus

Bacillus virus Φ29 is a double-stranded DNA (dsDNA) bacteriophage with a prolate icosahedral head and a short tail that belongs to the genus Salasvirus, order Caudovirales, and family Salasmaviridae. They are in the same order as phages PZA, Φ15, BS32, B103, M2Y (M2), Nf, and GA-1. First discovered in 1965, the Φ29 phage is the smallest Bacillus phage isolated to date and is among the smallest known dsDNA phages.

<span class="mw-page-title-main">Harald zur Hausen</span> German virologist and professor emeritus (born 1936)

Harald zur Hausen NAS EASA APS is a German virologist and professor emeritus. He has done research on cervical cancer and discovered the role of papilloma viruses in cervical cancer, for which he received the Nobel Prize in Physiology or Medicine 2008.

<span class="mw-page-title-main">Virus</span> Infectious agent that replicates in cells

A virus is a submicroscopic infectious agent that replicates only inside the living cells of an organism. Viruses infect all life forms, from animals and plants to microorganisms, including bacteria and archaea. Since Dmitri Ivanovsky's 1892 article describing a non-bacterial pathogen infecting tobacco plants and the discovery of the tobacco mosaic virus by Martinus Beijerinck in 1898, more than 9,000 of the millions of virus species have been described in detail. Viruses are found in almost every ecosystem on Earth and are the most numerous type of biological entity. The study of viruses is known as virology, a subspeciality of microbiology.

Rauchvirus is a genus of viruses in the order Caudovirales, in the family Podoviridae. Bacteria serve as natural hosts. The genus contains only one species: Bordetella virus BPP1.

Enterobacteria phage P4 is a temperate bacteriophage strain of species Escherichia virus P2 within genus Peduovirus, subfamily Peduovirinae, family Myoviridae. It is a satellite virus, requiring P2-related helper phage to grow lytically.

<span class="mw-page-title-main">Stephen C. Harrison</span> American chemist and pharmacologist

Stephen C. Harrison is professor of biological chemistry and molecular pharmacology, professor of pediatrics, and director of the Center for Molecular and Cellular Dynamics of Harvard Medical School, head of the Laboratory of Molecular Medicine at Boston Children's Hospital, and investigator of the Howard Hughes Medical Institute.

Synthetic virology is a branch of virology engaged in the study and engineering of synthetic man-made viruses. It is a multidisciplinary research field at the intersection of virology, synthetic biology, computational biology, and DNA nanotechnology, from which it borrows and integrates its concepts and methodologies. There is a wide range of applications for synthetic viral technology such as medical treatments, investigative tools, and reviving organisms.

<span class="mw-page-title-main">Helios Murialdo</span>

Helios Murialdo is a Chilean-Canadian molecular biologist, fiction writer, and ecologist. His research in the field of the assembly and structure of bacterial viruses contributed to the development of the first system for the cloning of human genes. He has published six novels and is a member of a group of conservationists that established a Natural Reserve in the central part of the Chilean Biodiversity Hotspot. Son of an Italian immigrant father and a Chilean mother of French descent, he has a brother and a sister. He is a member of the board of directors of the non-profit Fundación Ciencia & Vida, a scientific and technological institution with headquarters in Santiago, Chile. He is president of the NGO Corporación Altos de Cantillana, which manages the 26,000 acres of the Altos de Cantillana Natural Reserve in the coastal mountains of central Chile. He makes his home in this Natural Reserve, and spends the rest of the year in Toronto, Canada.

<i>Duplodnaviria</i> Realm of viruses

Duplodnaviria is a realm of viruses that includes all double-stranded DNA viruses that encode the HK97 fold major capsid protein. The HK97 fold major capsid protein is the primary component of the viral capsid, which stores the viral deoxyribonucleic acid (DNA). Viruses in the realm also share a number of other characteristics, such as an icosahedral capsid, an opening in the viral capsid called a portal, a protease enzyme that empties the inside of the capsid prior to DNA packaging, and a terminase enzyme that packages viral DNA into the capsid.

<i>Varidnaviria</i> Realm of viruses

Varidnaviria is a realm of viruses that includes all DNA viruses that encode major capsid proteins that contain a vertical jelly roll fold. The major capsid proteins (MCP) form into pseudohexameric subunits of the viral capsid, which stores the viral deoxyribonucleic acid (DNA), and are perpendicular, or vertical, to the surface of the capsid. Apart from this, viruses in the realm also share many other characteristics, such as minor capsid proteins (mCP) with the vertical jelly roll fold, an ATPase that packages viral DNA into the capsid, and a DNA polymerase that replicates the viral genome.

<span class="mw-page-title-main">COVI-VAC (U.S. COVID-19 vaccine)</span> Vaccine candidate against COVID-19

COVI-VAC is a COVID-19 vaccine developed by Codagenix, Inc. In December 2020, COVI-VAC started a Phase I clinical trial, involving 48 participants. The trial was scheduled to complete in June 2021, with results to be reported by May 2022. On September 29, 2021, Codagenix presented positive phase 1 data for COVI-VAC at IDWEEK2021. Data indicates that COVI-VAC is well tolerated, with no significant adverse events reported and that administration of the intranasal vaccine was immunogenic and capable of blocking nasal replication of the virus with minimal viral shedding, recorded at levels lower than those likely to result in subsequent transmission of COVID-19. Furthermore, COVI-VAC was shown to stimulate both serum and mucosal antibody immune responses.

References

  1. 1 2 3 4 5 6 7 8 9 10 "Viral Sensation". The Catholic University of America. Retrieved 27 October 2022.
  2. University, Catholic. "Venigalla B. Rao, Ph.D." The Catholic University of America. Retrieved 27 October 2022.
  3. "Search Results for "lean mean packaging machine"". NIH Director's Blog. Retrieved 27 October 2022.
  4. Fang, Qianglin; Tang, Wei-Chun; Fokine, Andrei; Mahalingam, Marthandan; Shao, Qianqian; Rossmann, Michael G.; Rao, Venigalla B. (4 October 2022). "Structures of a large prolate virus capsid in unexpanded and expanded states generate insights into the icosahedral virus assembly". Proceedings of the National Academy of Sciences. 119 (40): e2203272119. Bibcode:2022PNAS..11903272F. doi:10.1073/pnas.2203272119. ISSN   0027-8424. PMC   9546572 . PMID   36161892.{{cite journal}}: CS1 maint: PMC embargo expired (link)
  5. University, Catholic. "Professor Researches How Viruses Can Be Designed for Human Therapies". The Catholic University of America. Retrieved 27 October 2022.
  6. "T4 phage (bacteriophage T4)", The Dictionary of Genomics, Transcriptomics and Proteomics, Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, p. 1, 18 December 2015, doi:10.1002/9783527678679.dg13139, ISBN   9783527678679 , retrieved 27 October 2022
  7. University, Catholic. "Vaccine That Protects Against Anthrax and Plague Created, Should Be Stockpiled by Government". The Catholic University of America. Retrieved 27 October 2022.
  8. "How Catholic University is Fighting the Pandemic -". 1 May 2020. Retrieved 27 October 2022.
  9. Zhu, Jingen; Jain, Swati; Sha, Jian; Batra, Himanshu; Ananthaswamy, Neeti; Kilgore, Paul B.; Hendrix, Emily K.; Hosakote, Yashoda M.; Wu, Xiaorong; Olano, Juan P.; Kayode, Adeyemi; Galindo, Cristi L.; Banga, Simran; Drelich, Aleksandra; Tat, Vivian (30 August 2022). Hatfull, Graham F. (ed.). "A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine". mBio. 13 (4): e01822–22. doi:10.1128/mbio.01822-22. ISSN   2150-7511. PMC   9426593 . PMID   35900097.
  10. 1 2 University, Catholic. "Major Honor for Catholic University Professor Leading Research On New Nasal COVID Vaccine". The Catholic University of America. Retrieved 27 October 2022.
  11. "New needle-free nasal vaccine shows promise for COVID-19: A bacteriophage-based, highly efficacious, needle and adjuvant-free, mucosal COVID-19 vaccine". ScienceDaily. Retrieved 27 October 2022.
  12. "New Needle-free Nasal Vaccine Shows Promise for COVID-19". ASM.org. Retrieved 27 October 2022.
  13. "65 Fellows Elected into the American Academy of Microbiology". ASM.org. Retrieved 27 October 2022.
  14. "2021 Fellows of the National Academy of Inventors" (PDF). 4 April 2022.